|
1
|
Dasgupta P, Henshaw C, Youlden DR, Clark
PJ, Aitken JF and Baade PD: Global trends in incidence rates of
primary adult liver cancers: A systematic review and meta-analysis.
Front Oncol. 10:1712020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen QF, Jia ZY, Yang ZQ, Fan WL and Shi
HB: Transarterial chemoembolization monotherapy versus combined
transarterial chemoembolization-microwave ablation therapy for
hepatocellular carcinoma tumors ≤5 cm: A propensity analysis at a
single center. Cardiovasc Intervent Radiol. 40:1748–1755. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shen L, Zeng Q, Guo P, Huang J, Li C, Pan
T, Chang B, Wu N, Yang L, Chen Q, et al: Dynamically
prognosticating patients with hepatocellular carcinoma through
survival paths mapping based on time-series data. Nat Commun.
9:22302018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen QF, Xia JG, Li W, Shen LJ, Huang T
and Wu P: Examining the key genes and pathways in hepatocellular
carcinoma development from hepatitis B virus-positive cirrhosis.
Mol Med Rep. 18:4940–4950. 2018.PubMed/NCBI
|
|
5
|
Chen QF, Wu PH, Huang T, Shen LJ, Huang ZL
and Li W: Efficacy of treatment regimens for advanced
hepatocellular carcinoma: A network meta-analysis of randomized
controlled trials. Medicine (Baltimore). 98:e174602019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang ZL, Li W, Chen QF, Wu PH and Shen
LJ: Eight key long non-coding RNAs predict hepatitis virus positive
hepatocellular carcinoma as prognostic targets. World J
Gastrointest Oncol. 11:983–997. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen QF, Li W, Wu P, Shen L and Huang ZL:
Alternative splicing events are prognostic in hepatocellular
carcinoma. Aging (Albany NY). 11:4720–4735. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen QF, Huang T, Si-Tu QJ, Wu P, Shen L,
Li W and Huang Z: Analysis of competing endogenous RNA network
identifies a poorly differentiated cancer-specific RNA signature
for hepatocellular carcinoma. J Cell Biochem. 121:2303–2317. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang T, Chen QF, Chang BY, Shen LJ, Li W,
Wu PH and Fan WJ: TFAP4 promotes hepatocellular carcinoma invasion
and metastasis via activating the PI3K/AKT signaling pathway. Dis
Markers. 2019:71292142019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jeon Y, Kim H, Jang ES, Hong S, Kim JW,
Yoon YS, Cho JY, Han HS and Jeong SH: Expression profile and
prognostic value of glypican-3 in post-operative South Korean
hepatocellular carcinoma patients. APMIS. 124:208–215. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao JZ, Li J, Du JL and Li XL: Long
non-coding RNA HOTAIR is a marker for hepatocellular carcinoma
progression and tumor recurrence. Oncol Lett. 11:1791–1798. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Geng YJ, Xie SL, Li Q, Ma J and Wang GY:
Large intervening non-coding RNA HOTAIR is associated with
hepatocellular carcinoma progression. J Int Med Res. 39:2119–2128.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang T, He X, Chen A, Tan K and Du X:
LncRNA HOTAIR contributes to the malignancy of hepatocellular
carcinoma by enhancing epithelial-mesenchymal transition via
sponging miR-23b-3p from ZEB1. Gene. 670:114–122. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ono H, Motoi N, Nagano H, Miyauchi E,
Ushijima M, Matsuura M, Okumura S, Nishio M, Hirose T, Inase N and
Ishikawa Y: Long noncoding RNA HOTAIR is relevant to cellular
proliferation, invasiveness, and clinical relapse in small-cell
lung cancer. Cancer Med. 3:632–642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng C, Heintz N and Hatten ME: CNS gene
encoding astrotactin, which supports neuronal migration along glial
fibers. Science. 272:417–419. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Burchard J, Zhang C, Liu AM, Poon RT, Lee
NP, Wong KF, Sham PC, Lam BY, Ferguson MD, Tokiwa G, et al:
microRNA-122 as a regulator of mitochondrial metabolic gene network
in hepatocellular carcinoma. Mol Syst Biol. 6:4022010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roessler S, Jia HL, Budhu A, Forgues M, Ye
QH, Lee JS, Thorgeirsson SS, Sun Z, Tang ZY, Qin LX and Wang XW: A
unique metastasis gene signature enables prediction of tumor
relapse in early-stage hepatocellular carcinoma patients. Cancer
Res. 70:10202–10212. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lian Q, Wang S, Zhang G, Wang D, Luo G,
Tang J, Chen L and Gu J: HCCDB: A database of hepatocellular
carcinoma expression atlas. Genomics Proteomics Bioinformatics.
16:269–275. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Menyhárt O, Nagy Á and Győrffy B:
Determining consistent prognostic biomarkers of overall survival
and vascular invasion in hepatocellular carcinoma. R Soc Open Sci.
5:1810062018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li T, Fan J, Wang B, Traugh N, Chen Q, Liu
JS, Li B and Liu XS: TIMER: A web server for comprehensive analysis
of tumor-infiltrating immune cells. Cancer Res. 77:e108–e110. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ezponda T and Licht JD: Molecular
pathways: Deregulation of histone h3 lysine 27 methylation in
cancer-different paths, same destination. Clin Cancer Res.
20:5001–5008. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yuan SX, Tao QF, Wang J, Yang F, Liu L,
Wang LL, Zhang J, Yang Y, Liu H, Wang F, et al: Antisense long
non-coding RNA PCNA-AS1 promotes tumor growth by regulating
proliferating cell nuclear antigen in hepatocellular carcinoma.
Cancer Lett. 349:87–94. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chang H: Cleave but not leave: Astrotactin
proteins in development and disease. IUBMB Life. 69:572–577. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Iwakawa R, Kohno T, Totoki Y, Shibata T,
Tsuchihara K, Mimaki S, Tsuta K, Narita Y, Nishikawa R, Noguchi M,
et al: Expression and clinical significance of genes frequently
mutated in small cell lung cancers defined by whole Exome/RNA
sequencing. Carcinogenesis. 36:616–621. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Horn Z, Behesti H and Hatten ME:
N-cadherin provides a cis and trans ligand for astrotactin that
functions in glial-guided neuronal migration. Proc Natl Acad Sci
USA. 115:10556–10563. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Behesti H, Fore TR, Wu P, Horn Z, Leppert
M, Hull C and Hatten ME: ASTN2 modulates synaptic strength by
trafficking and degradation of surface proteins. Proc Natl Acad Sci
USA. 115:E9717–E9726. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wilson PM, Fryer RH, Fang Y and Hatten ME:
Astn2, a novel member of the astrotactin gene family, regulates the
trafficking of ASTN1 during glial-guided neuronal migration. J
Neurosci. 30:8529–8540. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yi S, Wang S, Zhao Q, Yao C, Gu Y, Liu J,
Gu X and Li S: miR-sc3, a novel microRNA, promotes Schwann cell
proliferation and migration by targeting Astn1. Cell Transplant.
25:973–982. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lachenmayer A, Alsinet C, Savic R,
Cabellos L, Toffanin S, Hoshida Y, Villanueva A, Minguez B, Newell
P, Tsai HW, et al: Wnt-pathway activation in two molecular classes
of hepatocellular carcinoma and experimental modulation by
sorafenib. Clin Cancer Res. 18:4997–5007. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Guichard C, Amaddeo G, Imbeaud S, Ladeiro
Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M,
Degos F, et al: Integrated analysis of somatic mutations and focal
copy-number changes identifies key genes and pathways in
hepatocellular carcinoma. Nat Genet. 44:694–698. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kan Z, Zheng H, Liu X, Li S, Barber TD,
Gong Z, Gao H, Hao K, Willard MD, Xu J, et al: Whole-genome
sequencing identifies recurrent mutations in hepatocellular
carcinoma. Genome Res. 23:1422–1433. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Y, Ye X, Zhang JB, Ouyang H, Shen Z,
Wu Y, Wang W, Wu J, Tao S, Yang X, et al: PROX1 promotes
hepatocellular carcinoma proliferation and sorafenib resistance by
enhancing β-catenin expression and nuclear translocation. Oncogene.
34:5524–5535. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yamashita T, Ji J, Budhu A, Forgues M,
Yang W, Wang HY, Jia H, Ye Q, Qin LX, Wauthier E, et al:
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating
cells with stem/progenitor cell features. Gastroenterology.
136:1012–1024. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang YL, Li Q, Yang XM, Fang F, Li J,
Wang YH, Yang Q, Zhu L, Nie HZ, Zhang XL, et al: SPON2 promotes
M1-like macrophage recruitment and inhibits hepatocellular
carcinoma metastasis by distinct integrin-Rho GTPase-Hippo
pathways. Cancer Res. 78:2305–2317. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yin Z, Ma T, Lin Y, Lu X, Zhang C, Chen S
and Jian Z: IL-6/STAT3 pathway intermediates M1/M2 macrophage
polarization during the development of hepatocellular carcinoma. J
Cell Biochem. 119:9419–9432. 2018. View Article : Google Scholar : PubMed/NCBI
|
